Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVIVE-HEART: HiCM-188 for Advanced Heart Failure
NCT07496372Phase 3Recruiting
- Sponsor
- Help Therapeutics
- Start
- Apr 2026
- Primary completion
- Jun 2027
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 3 trial of HiCM-188 in heart failure (HF), sponsored by Help Therapeutics. Started Apr 2026; status: recruiting.
02
Drugs
HiCM-188
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07496372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07496372.